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In their comment on our article, Baggott and Tamura sug-
gest that plasma total homocysteine concentrations may 
serve as a marker for excess body iron stores. They refer to 
a study conducted in five healthy volunteers in which non–
protein-bound iron was found to catalyze the conversion of 
thioethers, such as methionine and S-adenosylmethionine, 
into homocysteine (1). The authors hypothesize that the 
association between iron stores and homocysteine con-
centrations may underlie the apparent lack of any signif-
icant effects of B-vitamin supplementation on occlusive 
vascular disease.
In our recently published article, we reported that in-
creased concentrations of serum iron and ferritin were 
associated, cross-sectionally, with decreased cognitive per-
formance in the folic acid and carotid intima-media thick-
ness (FACIT) population (2). Plasma total homocysteine 
did not confound the observed associations as results were 
similar regardless if homocysteine concentrations were in-
cluded in the analyses.
We evaluated the relationship between serum iron param-
eters, HFE C282Y genotype, and plasma total homocyste-
ine in our study sample. We found that carriers of the HFE 
C282Y mutation did not differ significantly from noncarri-
ers in terms of homocysteine concentrations (t = −.677, 
p = .499). In addition, the concentrations of serum iron, to-
tal iron-binding capacity, transferrin saturation, and non–
transferrin-bound iron were not significantly correlated 
with homocysteine concentrations at baseline (r = −.064, 
p = .068; r = .005, p = .885; r = −.066, p = .060; and r = 
–.042, p = .236, respectively). However, serum ferritin, 
which is an indicator of body iron stores, showed a signif-
icant positive correlation with plasma total homocysteine 
at baseline (Spearman’s rank correlation coefficient = .125, 
p < .001).
At first glance, our data on serum ferritin seem to support 
the hypothesis that plasma total homocysteine concentra-
tions may serve as a marker for body iron stores as put for-
ward by Baggott and Tamura. Also, in line with the authors’ 
hypothesis, we did not observe any effect of 3-year folic 
acid supplementation on the risk of cardiovascular disease, 
as measured by carotid intima–media thickness, in the 
FACIT study, despite a significant reduction in plasma total 
homocysteine (3).
However, in a previous study performed in the FACIT 
population, we showed that serum iron parameters, includ-
ing ferritin and non–transferrin-bound iron, were not related 
to carotid intima–media thickness (4). These findings do not 
offer support for the authors’ hypothesis that excess free 
iron or iron stores might increase the risk of cardiovascular 
disease.
Furthermore, although we did not demonstrate any effect 
of 3-year supplementation with folic acid on cardiovascular 
disease risk, we did find a significant improvement in cogni-
tive performance concomitant with the observed decrease in 
homocysteine concentrations (3). In contrast, serum ferri-
tin, which showed a negative relationship with cognition, 
significantly increased over 3 years of follow-up (mean 
change [95% confidence interval] = 16.6 mg/L [6.7–26.4], 
p = .001) (2). These divergent findings suggest that the rela-
tionship between iron parameters and cognitive performance on 
the one hand and the relationship between folate–homocysteine 
metabolism and cognition on the other may be mediated by 
different mechanisms. In addition, our findings contradict the 
notion that excess iron stores may catalyze or promote the for-
mation of homocysteine in vivo. If plasma total homocysteine 
was to represent the amount of body iron stores, changes in 
homocysteine concentrations over time would be expected to 
parallel, at least in part, the changes in serum ferritin.
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A final remark should be made with regard to the range of 
plasma total homocysteine concentrations in the FACIT trial. 
As participants with plasma total homocysteine concentrations 
<13 mmol/L or >26 mmol/L were excluded from the study, it 
cannot be ruled out that the correlations between serum iron 
parameters and homocysteine observed in this study may dif-
fer to a certain extent from those obtained in other populations.
In conclusion, our findings regarding the associations be-
tween serum iron parameters, plasma total homocysteine, and 
risk of cardiovascular disease in a large population of older 
adults do not appear to support the notion that excess iron 
stores may, at least partly, be responsible for the increased risk 
of cardiovascular disease often attributed to homocysteine.
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